[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 22 of about 22
1. Añibarro Laca E, Pérez-Irezabal Pindado JC, Ibáñez Calle T, Llarena Ibarguren R: [Metastases from a rectal adenocarcinoma to the prepuce]. Arch Esp Urol; 2006 Sep;59(7):737-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Metastases from a rectal adenocarcinoma to the prepuce].
  • [Transliterated title] Metastasis subcutáneas en prepucio secundarias a adenocarcinoma de recto.
  • OBJECTIVE: We report one case of metastatic dissemination of a rectal adenocarcinoma to the prepuce.
  • METHODS: 61-year-old patient with the diagnosis of rectal adenocarcinoma treated 18 months before by surgery and chemotherapy.
  • RESULTS: The pathologic study reported a moderately differentiated intestinal type adenocarcinoma with high mitotic index infiltrating the squamous cell flat epithelium of the prepuce.
  • Surgical excision confirms the origin and may avoid bleeding and discomfort, and also may help with catheterization, which is many times necessary in the final stages.
  • [MeSH-major] Adenocarcinoma / secondary. Penile Neoplasms / secondary. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Arch Esp Urol. 2006 Nov;59(9):926; author reply 927 [17190224.001]
  • (PMID = 17078400.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


2. Mendenhall WM, Zlotecki RA, Snead FE, George TJ Jr, Marsh RD, Mendenhall CM, Rout WR: Radiotherapy in the treatment of resectable rectal adenocarcinoma. Am J Clin Oncol; 2009 Dec;32(6):629-38
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiotherapy in the treatment of resectable rectal adenocarcinoma.
  • The goal of treatment is to cure whereas maintaining sphincter function and minimizing toxicity.
  • Although the mainstay of the treatment is surgery, radiotherapy (RT) is used in a substantial proportion of patients depending on the location and extent of the tumor.
  • The aim of this article is to discuss the role of RT in patients with resectable rectal adenocarcinoma.
  • Results show that patients with T1N0 exophytic, well to moderately differentiated, mobile tumors < or = 3 cm in diameter may be treated with either transanal excision or endocavitary RT.
  • The advantages of endocavitary RT are that it is an outpatient procedure requiring, at most, local anesthesia and is suitable for elderly, infirm patients.
  • The disadvantage is that few of these treatment units are available.
  • The addition of concomitant chemotherapy probably enhances downstaging and may improve the likelihood of sphincter preservation.
  • Patients with T3 and/or N1 rectal cancers have a relatively high probability of local-regional recurrence after surgery alone.
  • Preoperative RT and postoperative RT combined with adjuvant chemotherapy have been shown to significantly reduce the risk of local-regional recurrence and improve survival.
  • Whether preoperative RT alone or combined with chemotherapy is more efficacious than postoperative chemoradiation remains unclear.
  • Depending on tumor location and extent, adjuvant RT may improve the probability of local-regional control and survival for patients with locally advanced rectal adenocarcinomas.
  • [MeSH-major] Rectal Neoplasms / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19593081.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 90
  •  go-up   go-down


3. Mendenhall WM, Rout WR, Zlotecki RA, Mitchell SE, Marsh RD, Copeland EM 3rd: Conservative treatment of rectal adenocarcinoma. Hematol Oncol Clin North Am; 2001 Apr;15(2):303-19
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conservative treatment of rectal adenocarcinoma.
  • Endocavitary radiotherapy and transrectal excision are highly effective treatments for properly selected patients with favorable early-stage rectal adenocarcinoma.
  • The likelihood of local control and survival after treatment with either modality is similar, and differences among various series probably reflect selection.
  • Suitable candidates for endocavitary radiotherapy or wide local excision are patients whose tumors are 3 cm or less in diameter, well-to-moderately differentiated, exophytic, mobile, limited to the submucosa on transrectal ultrasound, and within 10 cm of the anal verge.
  • The advantages of endocavitary irradiation are (1) it is an outpatient procedure, (2) it does not require anesthesia, and (3) it is less expensive than transrectal excision.
  • A disadvantage of wide local excision is that some patients who would be suitable for a local procedure alone must be subjected to a course of external-beam radiotherapy when they are found to have equivocal or positive margins.
  • Patients who should receive postoperative irradiation have tumors that exhibit one or more of the following characteristics: size greater than 3 cm in diameter, poorly differentiated, invasion of the muscularis propria, endothelial-lined space invasion, fragmented resection, equivocal or positive margins, or perineural invasion.
  • Patients thought to have transmural invasion before treatment are probably best treated with preoperative chemoradiation combined with major surgery, although a subset of patients can be downstaged and rendered suitable for a wide local excision.
  • [MeSH-major] Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Combined Modality Therapy. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11370495.001).
  • [ISSN] 0889-8588
  • [Journal-full-title] Hematology/oncology clinics of North America
  • [ISO-abbreviation] Hematol. Oncol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 56
  •  go-up   go-down


Advertisement
4. Sadahiro S, Suzuki T, Maeda Y, Tanaka Y, Nakamura T, Saguchi T, Yasuda S, Makuuchi H, Murayama C, Ohizumi Y: Predictors of tumor downsizing and regression with preoperative radiotherapy alone and with concomitant tegafur/uracil (UFT) for resectable advanced rectal adenocarcinoma. Hepatogastroenterology; 2007 Jun;54(76):1107-12
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Predictors of tumor downsizing and regression with preoperative radiotherapy alone and with concomitant tegafur/uracil (UFT) for resectable advanced rectal adenocarcinoma.
  • This study attempts to evaluate retrospectively the significance of apoptosis-related and proliferative indexes in biopsy specimens obtained before treatment as predictors of sensitivity to RT or to CRT for locally advanced rectal adenocarcinoma.
  • METHODOLOGY: The subjects were 96 patients with clinical T3-4/Nx/M0 adenocarcinoma of the middle third or lower third of the rectum.
  • Sixty-one patients were treated with preoperative RT alone (20 Gy in 10 fractions) [RT group] during 1991-1998, and 35 patients received concurrent oral tegafur/uracil (UFT) [CRT group] since 1999.
  • Radical surgery including TME and pelvic nerve preservation with 15 Gy of intraoperative RT was performed two weeks after completion of the preoperative radiation.
  • RESULTS: AI-positivity, p53-negativity, p21-positivity and well differentiated adenocarcinoma were predictors of high sensitivity in RT group, whereas AI-positivity alone was the predictor in CRT group.
  • The addition of UFT to RT increased sensitivity in patients with p53-positivity, p21-negativity and moderately differentiated adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / therapy. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Biomarkers, Tumor / analysis. Drug Resistance, Neoplasm. Radiation Tolerance. Rectal Neoplasms / therapy
  • [MeSH-minor] Aged. Apoptosis. Female. Humans. Male. Middle Aged. Preoperative Care. Prognosis. Tegafur / administration & dosage. Treatment Outcome. Uracil / administration & dosage

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17629049.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; 1-UFT protocol
  •  go-up   go-down


5. Kanoh T, Ohnishi T, Danno K, Watanabe A, Nakamura H, Tsukao Y, Inatome J, Kim C, Kagara N, Taniguchi H, Kimura Y, Tono T, Nakano Y, Monden T, Imaoka S: [A case of successfully treated lower rectal cancer with both inguinal lymph nodes by chemoradiotherapy]. Gan To Kagaku Ryoho; 2010 Nov;37(12):2611-3
Hazardous Substances Data Bank. LEUCOVORIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of successfully treated lower rectal cancer with both inguinal lymph nodes by chemoradiotherapy].
  • We report a case of successfully treated lower rectal cancer with both inguinal lymph nodes by chemoradiotherapy.
  • A colonoscopy revealed primary rectal cancer.
  • The histological diagnosis was well to moderately differentiated adenocarcinoma.
  • A computed tomography showed metastases to pararectal, both inguinal lymph nodes and right external iliac.
  • After a ileostomy construction was done, he was treated with intensity modulated radiotherapy (a total 50.4 Gy) and chemotherapy with FOLFOX.
  • Nine months after radiation therapy, however, multiple lung and liver metastases were observed by a computed tomography, which were treated by systemic chemotherapy with FOLFOX and bevacizumab.
  • [MeSH-major] Adenocarcinoma / therapy. Lymphatic Metastasis. Rectal Neoplasms / therapy
  • [MeSH-minor] Angiogenesis Inhibitors / administration & dosage. Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal, Humanized. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Bevacizumab. Combined Modality Therapy. Fluorouracil / therapeutic use. Humans. Ileostomy. Inguinal Canal. Leucovorin / therapeutic use. Male. Middle Aged. Organoplatinum Compounds / therapeutic use. Radiotherapy, Intensity-Modulated

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224655.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Organoplatinum Compounds; 2S9ZZM9Q9V / Bevacizumab; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; Folfox protocol
  •  go-up   go-down


6. Matsushita D, Kitazono M, Baba K, Ishigami S, Shinchi H, Ueno S, Ogawa H, Natsugoe S: [A case of advanced rectal cancer with liver and lung metastasis showing a complete response by neo-adjuvant FOLFOX4 chemotherapy]. Gan To Kagaku Ryoho; 2010 Jan;37(1):173-6
Hazardous Substances Data Bank. LEUCOVORIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of advanced rectal cancer with liver and lung metastasis showing a complete response by neo-adjuvant FOLFOX4 chemotherapy].
  • Colonoscopy detected rectal cancer and sigmoid al polyps.
  • The biopsy results suggested that the rectal lesion was well- to moderately-differentiated adenocarcinoma and the sigmoidal polyp contained well -differentiated adenocarcinoma.
  • We judged the case to be inoperable and decided to start systemic chemotherapy (FOLFOX4).
  • After treatment with chemotherapy, the tumor shrank and metastatic lesions disappeared.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Liver Neoplasms / secondary. Lung Neoplasms / secondary. Rectal Neoplasms / drug therapy
  • [MeSH-minor] Antimetabolites, Antineoplastic / administration & dosage. Antineoplastic Agents, Phytogenic / administration & dosage. Camptothecin / administration & dosage. Camptothecin / analogs & derivatives. Fluorouracil / administration & dosage. Humans. Leucovorin / administration & dosage. Male. Middle Aged. Neoadjuvant Therapy

  • Genetic Alliance. consumer health - Liver cancer.
  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20087057.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents, Phytogenic; 7673326042 / irinotecan; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


7. Colonias A, Farinash L, Miller L, Jones S, Medich DS, Greenberg L, Miller R, Parda DS: Multidisciplinary treatment of synchronous primary rectal and prostate cancers. Nat Clin Pract Oncol; 2005 May;2(5):271-4; quiz 1 p following 274
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multidisciplinary treatment of synchronous primary rectal and prostate cancers.
  • BACKGROUND: A 58-year-old Caucasian man with a history of irritable bowel syndrome and occasional rectal bleeding presented with a 4-week history of progressive, bright red blood per rectum.
  • A digital rectal examination revealed a 3 cm distal, midrectal mass.
  • INVESTIGATIONS: Digital rectal examination, colonoscopy, rectal mass biopsy, endorectal ultrasound, transrectal ultrasound-guided prostate biopsy, CT scan and MRI.
  • DIAGNOSIS: Clinical stage III (T3N1M0), moderately differentiated adenocarcinoma of the rectum and clinical stage II (T1cN0M0) adenocarcinoma of the prostate.
  • MANAGEMENT: Intensity-modulated radiation therapy, chemoradiation, chemotherapy, hormone therapy and surgery.
  • [MeSH-major] Adenocarcinoma / pathology. Neoplasms, Multiple Primary / pathology. Prostatic Neoplasms / pathology. Rectal Neoplasms / pathology
  • [MeSH-minor] Antineoplastic Agents, Hormonal / therapeutic use. Combined Modality Therapy. Diagnosis, Differential. Gastrointestinal Hemorrhage / etiology. Humans. Male. Middle Aged. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16264963.001).
  • [ISSN] 1743-4254
  • [Journal-full-title] Nature clinical practice. Oncology
  • [ISO-abbreviation] Nat Clin Pract Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal
  •  go-up   go-down


8. Takahashi T, Itoh Y: [Effect on neoadjuvant chemotherapy using s-1 for unresectable liver metastasis from rectal cancer-a case report]. Gan To Kagaku Ryoho; 2009 Dec;36(13):2669-72
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect on neoadjuvant chemotherapy using s-1 for unresectable liver metastasis from rectal cancer-a case report].
  • The patient was a 42-year-old female who had advanced rectal cancer(Ra, type 2)with liver metastasis.
  • She underwent low anterior resection for primary rectal cancer at first after she was given S-1 80 mg/day(14 days)for a histological effect judgment.
  • The pathological diagnosis was moderately-differentiated adenocarcinoma, ss, n1, and the histological effect was Grade 1a.
  • Because CT showed reduction of liver metastasis after the operation, she was treated with 2 courses of chemotherapy using S-1.
  • In January, 2005, she underwent hepatectomy and the pathological diagnosis was moderately-differentiated adenocarcinoma, metastasis and the histological effect was Grade 1a.
  • We experienced this case in which preoperative S-1 proved effective for liver metastasis from rectal cancer.
  • [MeSH-major] Adenocarcinoma / pathology. Antimetabolites, Antineoplastic / therapeutic use. Liver Neoplasms / secondary. Liver Neoplasms / therapy. Oxonic Acid / therapeutic use. Rectal Neoplasms / pathology. Tegafur / therapeutic use
  • [MeSH-minor] Adult. Drug Combinations. Female. Hepatectomy. Humans. Neoadjuvant Therapy

  • Genetic Alliance. consumer health - Liver cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20009478.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid
  •  go-up   go-down


9. Osawa T, Shirasaki S, Tamamura H, Hinoshita T: [A case successfully treated with multidisciplinary treatment against recurrence of lateral lymph node and liver for rectal cancer]. Gan To Kagaku Ryoho; 2010 Jul;37(7):1393-5
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case successfully treated with multidisciplinary treatment against recurrence of lateral lymph node and liver for rectal cancer].
  • We report a case successfully treated with multidisciplinary treatment against recurrence of lateral lymph node and liver for rectal cancer.
  • The patient was a 61-year-old man with lower rectal cancer (moderately-differentiated tubular adenocarcinoma).
  • Final findings were pA, pN1, sH0, sP0, cM0, fStage IIIa, and S-1 was given as postoperative adjuvant chemotherapy.
  • Chemotherapy with FOLFOX4 was performed.
  • However, because of elevated CEA, concurrent chemoradiotherapy with FOLFOX4 and radiation (60 Gy) was performed.
  • Though CEA decreased once after chemoradiotherapy, it rose again in chemotherapy with FOLFOX4.
  • The chemotherapy regimen was changed to FOLFIRI.
  • Thereafter, chemotherapy with CPT-11 was continuously performed.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Liver Neoplasms / drug therapy. Rectal Neoplasms / drug therapy
  • [MeSH-minor] Humans. Lymphatic Metastasis / radiography. Lymphatic Metastasis / radionuclide imaging. Male. Middle Aged. Positron-Emission Tomography. Recurrence. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Liver cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20647735.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


10. Yamaguchi Y, Ohshita A, Hironaka K, Emi M, Kawabuchi Y, Sakatani A, Arihiro K: Neoadjuvant therapy of rectal cancer using oral tegaful-uracil (UFT) plus concomitant radiotherapy--a case report. Hiroshima J Med Sci; 2005 Sep;54(3):87-91
Genetic Alliance. consumer health - Rectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neoadjuvant therapy of rectal cancer using oral tegaful-uracil (UFT) plus concomitant radiotherapy--a case report.
  • A 59-year-old male patient with rectal cancer 2 cm in diameter (T2) at the peritoneal reflection with suspicious left lateral node metastasis was treated with 400 mg of preoperative oral uracil and tegaful (UFT) for 5 weeks, 5 days a week in combination with concomitant radiotherapy of 45 Gy per 25 fractions for 5 weeks.
  • After resting for another 5 weeks, colon fiberscopy, barium enema, and computed tomography revealed a trace of the primary tumor and a 40% shrinkage of the lateral metastasis.
  • The serum CEA level decreased to the normal range during treatment.
  • The adverse effects were nausea, bloody stool and elevation of transaminase, all at grade 1.
  • The preoperative treatment did not affect any operative procedures, and no postoperative complications occurred.
  • The surgical specimen showed that the rectal tumor had been remarkably shrunk by the preoperative treatment, to the level of a superficial type tumor.
  • Histological analysis indicated moderately differentiated adenocarcinoma cells that were present at only 2 mm in diameter in the mucosal layer, 6 mm in the submucosal layer, and 1 mm or less in the muscular layer with scar formation.
  • These results suggest that preoperative oral UFT plus concomitant radiotherapy may be a feasible, tolerable and effective treatment for patients with rectal cancer.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / radiotherapy. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Administration, Oral. Humans. Male. Middle Aged. Neoadjuvant Therapy. Tegafur / administration & dosage. Uracil / administration & dosage

  • Genetic Alliance. consumer health - Oral cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16180702.001).
  • [ISSN] 0018-2052
  • [Journal-full-title] Hiroshima journal of medical sciences
  • [ISO-abbreviation] Hiroshima J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil
  •  go-up   go-down


11. Franceschi F, Fini L, Manno A, Carloni E, Zocco MA, Di Caro S, Picciocchi A, Coco C, Gasbarrini G, Gasbarrini A: Gene-expression profile of colorectal adenocarcinoma tissues identified by gene microarray analysis. J Clin Oncol; 2004 Jul 15;22(14_suppl):3651

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gene-expression profile of colorectal adenocarcinoma tissues identified by gene microarray analysis.
  • Aim of the study was to identify the gene expression of colorectal adenocarcinoma tissues compared to the normal mucosa.
  • METHODS: RNA was extracted from 3 samples of moderately differentiated sporadic rectal adenocarcinoma and 3 samples of normal rectal mucosa obtained from the same patients and hybridized against the human U133A array set.
  • Gene expression of tumoral tissues and normal samples was compared; a minimum of 3 times fold differential expression among the same genes in neoplastic and normal samples was considered as significant.
  • Real-time PCR (Roche, Manheim) using the same RNA was also performed on a pool of either up- or down-regulated randomly-selected genes to validate the results.
  • 537 genes were upregulated while 13 genes were downregulated in neoplastic tissues.
  • The up-regulated genes included angiogenic factors (VEGF, PD-ECGF, EGF), markers of proliferation (PCNA), tumoral markers (CEA, ACE), genes involved in chemotherapy activity (Farnesyl-transferase, Topoisomerase-1) and several other genes of unclear function.
  • CONCLUSIONS: Colorectal cancer tissues show a different gene expression compared to the normal mucosa.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28014587.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Blair S, Ellenhorn JD: Transanal excision for low rectal cancers is curative in early-stage disease with favorable histology. Am Surg; 2000 Sep;66(9):817-20

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transanal excision for low rectal cancers is curative in early-stage disease with favorable histology.
  • Controversy still exists as to the optimal treatment of early-stage low rectal cancers.
  • We identified 20 patients from our prospective tumor registry database that underwent transanal resection of early rectal cancers between 1988 and 1998.
  • All T1 lesions were well or moderately well differentiated, and none had lymphovascular invasion.
  • Four patients had postoperative adjuvant therapy (radiation alone, two; radiation and chemotherapy, two) for close margins after they refused an abdominal perineal resection.
  • This series suggests that transanal excision is a safe and effective treatment for selected early low rectal cancers with favorable histology.
  • [MeSH-major] Adenocarcinoma / surgery. Anal Canal / surgery. Rectal Neoplasms / surgery
  • [MeSH-minor] Aged. Anastomosis, Surgical. Carcinoma in Situ / pathology. Carcinoma in Situ / surgery. Chemotherapy, Adjuvant. Colon / surgery. Colostomy. Databases as Topic. Female. Follow-Up Studies. Humans. Male. Neoplasm Recurrence, Local. Neoplasm Staging. Perineum / surgery. Postoperative Complications / surgery. Prospective Studies. Radiotherapy, Adjuvant. Registries. Safety. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10993607.001).
  • [ISSN] 0003-1348
  • [Journal-full-title] The American surgeon
  • [ISO-abbreviation] Am Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


13. Sugimoto S, Noura S, Seki Y, Ohue M, Motoori M, Goto K, Kishi K, Eguchi H, Yamada T, Miyashiro I, Ohigashi H, Yano M, Ishikawa O, Tanaka E, Nishiyama K: [A case of metastatic liver cancer from rectal cancer demonstrating a clinical CR with 3D-CRT]. Gan To Kagaku Ryoho; 2008 Nov;35(12):2171-3
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of metastatic liver cancer from rectal cancer demonstrating a clinical CR with 3D-CRT].
  • The patient was a 62-year-old man who underwent a low anterior resection for rectal cancer.
  • The tumor was a moderately differentiated adenocarcinoma, type 2 in the Japanese classification of colorectal carcinoma.
  • He did not receive any adjuvant chemotherapy.
  • We diagnosed liver metastasis of the rectal cancer.
  • The patient refused a surgery and chemotherapy.
  • He was given a total dose of 60 Gy/10 fractions/10 days with 3D-CRT.
  • At 19 months from the radio therapy, the disease was diagnosed as CR because no tumors were detected.
  • 3D-CRT appears to be effective for liver metastasis from the rectal cancer.
  • [MeSH-major] Liver Neoplasms / radiotherapy. Liver Neoplasms / secondary. Rectal Neoplasms / pathology. Rectal Neoplasms / radiotherapy
  • [MeSH-minor] Carcinoembryonic Antigen / blood. Humans. Imaging, Three-Dimensional. Male. Middle Aged. Remission Induction. Tomography, X-Ray Computed


14. Fujita T, Kawasaki K, Ohno M, Kanaji S, Kobayashi I, Ueno K, Tsuchida S, Osawa M, Fujino Y, Kanbara Y, Nakamura T: [A successfully resected case of rectal cancer with liver metastases treated with mFOLFOX6 and bevacizumab]. Gan To Kagaku Ryoho; 2009 Apr;36(4):663-6
Hazardous Substances Data Bank. LEUCOVORIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A successfully resected case of rectal cancer with liver metastases treated with mFOLFOX6 and bevacizumab].
  • Colonoscopy revealed type 2 tumor at rectum.
  • Computed tomography (CT)demonstrated lymph node metastasis in front of sacrum and two low density areas which were suspected metastases in the liver.
  • The patient was diagnosed stageIV rectal cancer and resected primary focus and lymph node metastasis.
  • [ Ra-RS, ant, type 2, moderately differentiated adenocarcinoma, ly1, v3, pSE, pN2, sH1(Grade C), sP0, pM1(No. 270)]without liver resection.
  • The level of CEA decreased to normal level and CT revealed a partial response after 4 cycles of systemic chemotherapy.
  • Histological response was Grade 2 at liver metastases.
  • [MeSH-major] Antibodies, Monoclonal / immunology. Antibodies, Monoclonal / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Liver Neoplasms / drug therapy. Liver Neoplasms / secondary. Rectal Neoplasms / drug therapy. Rectal Neoplasms / pathology
  • [MeSH-minor] Antibodies, Monoclonal, Humanized. Bevacizumab. Carcinoembryonic Antigen / blood. Fluorouracil / therapeutic use. Humans. Immunotherapy. Leucovorin / therapeutic use. Male. Organoplatinum Compounds / therapeutic use. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Liver cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19381044.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Carcinoembryonic Antigen; 0 / Organoplatinum Compounds; 2S9ZZM9Q9V / Bevacizumab; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; Folfox protocol
  •  go-up   go-down


15. Kumazawa S, Murata Y, Ishita T, Nakamura S, Tamura N, Oikawa Y, Kubo Y, Kurata N, Yagi K, Hattori S, Bando M, Mori M, Matsumoto K, Sato Y, Machinami R: [A case of advanced rectal cancer with multiple liver metastases successfully treated by perioperative administration of UFT and oral leucovorin]. Gan To Kagaku Ryoho; 2010 Sep;37(9):1817-20
Hazardous Substances Data Bank. LEUCOVORIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of advanced rectal cancer with multiple liver metastases successfully treated by perioperative administration of UFT and oral leucovorin].
  • The patient was a sixty-five-year-old man who had an advanced rectal cancer (Ra, type 2) with liver metastases.
  • The pathological finding was moderately-differentiated adenocarcinoma.
  • He was treated with 5-FU via the hepatic artery, but the therapy failed due to catheter infection after 3 postoperative months.
  • Then, he received general 5-FU/l-LV therapy intravenously from 3 to 8 months after the operation, and oral UFT/LV (Uzel®) from 9 to 22 months.
  • Next, we switched to single UFT therapy at 23 months because CT findings showed remarkable calcification in the liver metastases.
  • We switched the chemotherapy again to UFT/Uzel and mFOLFOX6, but decided to perform hepatectomy of S6/7 at 39 months since it proved ineffective.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Leucovorin / therapeutic use. Liver Neoplasms / drug therapy. Rectal Neoplasms / drug therapy
  • [MeSH-minor] Administration, Oral. Aged. Combined Modality Therapy. Hepatectomy. Humans. Male. Neoplasm Staging. Tegafur / administration & dosage. Tegafur / therapeutic use. Tomography, X-Ray Computed. Uracil / administration & dosage. Uracil / therapeutic use

  • Genetic Alliance. consumer health - Liver cancer.
  • Genetic Alliance. consumer health - Oral cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20841955.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; Q573I9DVLP / Leucovorin; 1-UFT protocol
  •  go-up   go-down


16. Katsumata K, Ichimiya H, Wakana Y, Okada K, Kato K, Aoki T: [Case report of two colorectal cancer patients with liver metastasis showing favorable response to fluorouracil and l-leucovorin therapy]. Gan To Kagaku Ryoho; 2004 Apr;31(4):623-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Case report of two colorectal cancer patients with liver metastasis showing favorable response to fluorouracil and l-leucovorin therapy].
  • We treated 2 patients with colorectal cancer accompanied by liver metastasis who showed favorable response to combined treatment with fluorouracil and l-Leucovorin.
  • Case 1 was a 40-year-old man with rectal carcinoma (moderately differentiated adenocarcinoma; se, n1, p1, H0, stage IV).
  • As of 30 months post-treatment the patient was alive.
  • Case 2 was a 60-year-old man with rectal carcinoma (well differentiated adenocarcinoma; ss, n1, p0, H1, stage IV).
  • Adverse drug reactions in both patients were controlled on an outpatient basis.
  • While in the past liver metastasis has been treated by hepatic arterial infusion chemotherapy, a combination therapy with fluorouracil and l-Leucovorin can be used on an outpatient basis and results in a favorable response.
  • This suggests that this combination therapy has clinical significance.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / secondary. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Liver Neoplasms / drug therapy. Liver Neoplasms / secondary. Rectal Neoplasms / drug therapy
  • [MeSH-minor] Adult. Drug Administration Schedule. Fluorouracil / administration & dosage. Hepatic Artery. Humans. Infusions, Intra-Arterial. Leucovorin / administration & dosage. Male. Middle Aged. Peritoneal Neoplasms / secondary

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • Genetic Alliance. consumer health - Liver cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15114713.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


17. Nishimura R, Teramoto N, Tanada M, Kurita A, Mogami H: Inflammatory pseudotumor of the liver associated with malignant disease: report of two cases and a review of the literature. Virchows Arch; 2005 Sep;447(3):660-4
MedlinePlus Health Information. consumer health - Liver Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The first patient was a 63-year-old woman who underwent distal gastrectomy and partial hepatectomy under a diagnosis of stomach cancer with liver metastasis.
  • The second patient was a 66-year-old man who had undergone surgery for rectal cancer 6 years previously and underwent partial hepatectomy under a diagnosis of metastasis of rectal cancer to the liver.
  • The gastric cancer was a papillary adenocarcinoma limited to the mucosa, and the rectal cancer was a moderately differentiated adenocarcinoma limited to the subserosa.
  • The cut surface showed that both masses were well circumscribed and divided into lobules by fibrous tissue.
  • Obliterating phlebitis suggesting infection via the portal vein was seen in the adjacent liver tissue in both cases.
  • According to previous cases reported in the literature, there are three types of cancers associated with hepatic IPT: gastrointestinal tract cancer, biliary tract cancer, and cancers that need strong systemic chemotherapy.
  • The underlying cancer types of IPT of the liver are almost similar to those associated with pyogenic liver abscesses suggesting the etiological correlation between IPT and abscesses of the liver.
  • [MeSH-major] Adenocarcinoma / complications. Adenocarcinoma / pathology. Granuloma, Plasma Cell / complications. Granuloma, Plasma Cell / pathology. Liver Diseases / pathology
  • [MeSH-minor] Aged. Female. Humans. Immunohistochemistry. Liver Abscess / complications. Liver Abscess / pathology. Male. Middle Aged. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery. Stomach Neoplasms / pathology. Stomach Neoplasms / surgery

  • Genetic Alliance. consumer health - Liver Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Surg. 1993 Dec;128(12):1358-64; discussion 1364 [8250709.001]
  • [Cites] Intern Med. 1998 Jun;37(6):542-5 [9678690.001]
  • [Cites] Arch Surg. 1998 Mar;133(3):242-5 [9517733.001]
  • [Cites] Am J Surg Pathol. 1993 Mar;17(3):231-8 [8382011.001]
  • [Cites] Am J Surg Pathol. 1996 Jun;20(6):747-53 [8651355.001]
  • [Cites] Surg Today. 2000;30(6):530-3 [10883465.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):761-8 [11395553.001]
  • [Cites] Am J Gastroenterol. 1991 Feb;86(2):238-40 [1992642.001]
  • [Cites] AJR Am J Roentgenol. 1999 Oct;173(4):1049-54 [10511176.001]
  • [Cites] J Gastroenterol. 2000;35(4):304-9 [10777162.001]
  • [Cites] Pathol Res Pract. 1997;193(7):519-25; discussion 526 [9342759.001]
  • [Cites] Cancer. 1990 Apr 1;65(7):1583-90 [2155699.001]
  • [Cites] J Gastroenterol. 1995 Jun;30(3):408-12 [7647910.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):721-31 [11395549.001]
  • [Cites] Eur J Pediatr Surg. 1999 Oct;9(5):343-6 [10584199.001]
  • [Cites] Clin Diagn Lab Immunol. 2004 Jan;11(1):123-30 [14715558.001]
  • [Cites] Med Pediatr Oncol. 1992;20(2):172-5 [1310343.001]
  • [Cites] Eur Radiol. 2002 Oct;12(10):2484-7 [12271389.001]
  • (PMID = 15968548.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


18. Kravarusic D, Feigin E, Dlugy E, Steinberg R, Baazov A, Erez I, Lazar L, Kapuller V, Grunspan M, Ash S, Freud E: Colorectal carcinoma in childhood: a retrospective multicenter study. J Pediatr Gastroenterol Nutr; 2007 Feb;44(2):209-11
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this multicenter study was to document the clinical profile, treatment and prognosis of colorectal carcinoma in children in Israel.
  • PATIENTS AND METHODS: The clinical, laboratory, therapeutic, and prognostic parameters of all 7 children from 4 medical centers in Israel who were diagnosed with colorectal carcinoma over a 25-y period were reviewed.
  • RESULTS: Patients presented with rectal bleeding (4 of 7), abdominal pain (2 of 7), and abdominal distension (2 of 7).
  • Average time to diagnosis was 6 months.
  • Six patients underwent surgery (1 refused), and 5 received chemotherapy.
  • Histopathological studies showed poorly differentiated mucinous adenocarcinoma, signet-ring type, in 4 cases, moderately differentiated adenocarcinoma in 2, and well-differentiated carcinoma in 1.
  • Heightened physician awareness of the possibility of this disease in children, with special attention to adolescents with predisposing factors and rectal bleeding, could help to improve outcome.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / therapy. Colorectal Neoplasms / diagnosis. Colorectal Neoplasms / therapy
  • [MeSH-minor] Adolescent. Antineoplastic Agents / therapeutic use. Child, Preschool. Colectomy. Female. Humans. Israel. Male. Prognosis. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17255833.001).
  • [ISSN] 1536-4801
  • [Journal-full-title] Journal of pediatric gastroenterology and nutrition
  • [ISO-abbreviation] J. Pediatr. Gastroenterol. Nutr.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


19. Kurita M, Kato Y, Tamura Y, Suzuki K, Yamanaka H: [A case of prostate cancer treated with combined androgen-blockade]. Gan To Kagaku Ryoho; 2000 Feb;27(2):307-10
Hazardous Substances Data Bank. DIETHYLSTILBESTROL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A digital rectal examination revealed an enlarged, elastic, and hard prostate with an irregular surface.
  • Prostatic biopsy was done and the pathological diagnosis was moderately differentiated adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / drug therapy. Androgen Antagonists / administration & dosage. Antineoplastic Agents / administration & dosage. Diethylstilbestrol / analogs & derivatives. Flutamide / administration & dosage. Prostatic Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10700907.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] JAPAN
  • [Chemical-registry-number] 0 / Androgen Antagonists; 0 / Antineoplastic Agents; 731DCA35BT / Diethylstilbestrol; 76W6J0943E / Flutamide; A0E0NMA80F / fosfestrol
  •  go-up   go-down


20. Takeda Y, Hasuike Y, Mishima H, Nishisho I, Kikkawa N: [Case report--efficacy of short-term intraarterial 5-fluorouracil for liver metastasis from colorectal cancer]. Gan To Kagaku Ryoho; 2000 Oct;27(12):1838-41
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 57-year-old woman with a solitary liver metastasis from rectal cancer was treated by continuous HAI of 5-FU (1,000 mg/day) for 6 days.
  • Computed tomography revealed a decrease of 55.6% in the size of the liver tumor.
  • Histological examination of the resected tumor showed marked degeneration, necrosis, fibrosis, and calcification with viable moderately differentiated adenocarcinoma cells.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / secondary. Antimetabolites, Antineoplastic / administration & dosage. Colorectal Neoplasms / pathology. Fluorouracil / administration & dosage. Liver Neoplasms / drug therapy. Liver Neoplasms / secondary
  • [MeSH-minor] Combined Modality Therapy. Drug Administration Schedule. Female. Humans. Infusions, Intra-Arterial. Middle Aged

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • Genetic Alliance. consumer health - Liver cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11086425.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] JAPAN
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


21. Kömürcü S, Ozet A, Oztürk B, Arpaci F, Altundağ MK, Tezcan Y: Colon cancer during pregnancy. A case report. J Reprod Med; 2001 Jan;46(1):75-8
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CASE: A 33-year-old woman, gravida 2, para 1, was admitted at 30 weeks' gestational age with a history of rectal bleeding and right upper quadrant pain.
  • Histologic examination confirmed serosal and lymph node invasion of moderately differentiated mucous-secreting adenocarcinoma of the cecum and adenocarcinoma metastatic to the liver.
  • The patient received systemic chemotherapy.
  • [MeSH-major] Adenocarcinoma / diagnosis. Colonic Neoplasms / diagnosis. Pregnancy Complications, Neoplastic / diagnosis
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biopsy. Cesarean Section. Embolization, Therapeutic. Fatal Outcome. Female. Gestational Age. Hepatic Artery. Humans. Liver Neoplasms / secondary. Pregnancy. Prognosis. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11209639.001).
  • [ISSN] 0024-7758
  • [Journal-full-title] The Journal of reproductive medicine
  • [ISO-abbreviation] J Reprod Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Neagoe A, Chira O, Zaharia T, Cruciat C: Education and management of patients with familial adenomatous polyposis. Are we making progress? A case report. Rom J Gastroenterol; 2004 Dec;13(4):333-6
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 25-year-old male patient was admitted to our clinic for abdominal pain, diarrhea, intermittent rectal bleeding and weight loss.
  • Histopathological diagnosis revealed moderately differentiated adenocarcinoma.
  • Adjuvant chemotherapy was carried out.
  • Two of them were diagnosed with adenomatous polyposis - the first with classic FAP and the other one with the attenuated type (AFAP).
  • [MeSH-major] Adenocarcinoma / pathology. Adenomatous Polyposis Coli. Colorectal Neoplasms / pathology. Patient Education as Topic

  • Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).
  • Genetic Alliance. consumer health - Familial Polyposis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15624032.001).
  • [ISSN] 1221-4167
  • [Journal-full-title] Romanian journal of gastroenterology
  • [ISO-abbreviation] Rom J Gastroenterol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Romania
  • [Number-of-references] 18
  •  go-up   go-down






Advertisement